跳至主要内容
临床试验/NCT01073566
NCT01073566已完成2 期

The Effects of Finesse on Glycemic Control in Adults With Diabetes Using MDI: Finesse vs. Pen or Syringe and Vial as Bolus Prandial Insulin Device

Calibra Medical, Inc.10 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
38
试验地点
10
主要终点
Mean Daily Blood Glucose

研究概览

简要总结

The purpose of this study is to evaluate that Finesse, for prandial insulin bolusing when used in conjunction with basal insulin, achieves equivalent glycemic control when compared to multiple daily injections and to evaluate its preference.

详细描述

The aim of this feasibility study is to compare efficacy, device satisfaction and quality of life (QOL) in people with type 1 or 2 diabetes delivering mealtime insulin using a novel insulin bolus-patch (Finesse™; Calibra Medical, Inc., Redwood City, CA) versus current devices that deliver bolus insulin (pen/syringe). All subjects injected their basal insulin using their current pen/syringe.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes mellitus on intensive insulin therapy

排除标准

  • Insulin pump therapy
  • Current use of NPH or regular insulin
  • Severe hypoglycemic episodes in prior 6 months
  • Unstable cardiac disease, hepatic, or renal function

结局指标

主要结局

Mean Daily Blood Glucose

时间窗: 6 weeks

Equivalence of Finesse to Usual Injection Device in Mean Daily Blood Glucose

次要结局

  • Glucose Profiles Per Day(6 weeks)
  • Insulin Delivery System Rating(6 weeks)
  • Self-reported Hypoglycemic Episodes(6 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Feasibility Study of Finesse for Bolus Prandial... | 临床试验